3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Li et al. Sci China Chem . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
2.1.3 N,N-bis(3,5-di(pyrid-4-yl)phenyl)-p-chloroaniline
(3)
Using the similar procedure for the synthesis of 2, compound
(68.1 mg, 0.50 mmol), Pd(dba)2 (23.0 mg, 0.040 mmol),
tBu3P (8.1 mg, 0.040 mmol), and NaOtBu (120 mg,
1.25 mmol) as a light green solid in 35% yield (105 mg of
1
3
was prepared from 3,5-(pyrid-2-yl)bromobenzene
product was isolated). H NMR (400 MHz, CDCl3): δ 8.64
(388 mg, 1.25 mmol), 4-chloroaniline (63.8 mg,
(d, J=6.1 Hz, 8H), 7.44 (d, J=6.3 Hz, 14H), 7.16 (d, J=
8.9 Hz, 2H), 6.75 (d, J=9.0 Hz, 2H), 3.00 (s, 6H). 13C NMR
(100 MHz, CDCl3): δ 150.63, 149.79, 148.71, 147.87,
140.68, 135.55, 128.03, 121.86, 121.57, 119.61, 113.88,
40.86. MALDI-HRMS calcd. for [M]+ C40H32N6: 596.2683.
Found: 596.2683.
0.50 mmol), Pd(dba)2 (23.0 mg, 0.040 mmol), tBu3P
(8.1 mg, 0.040 mmol), and NaOtBu (120 mg, 1.25 mmol) as
a yellow powder in 71% yield (209.2 mg of product was
isolated). 1H NMR (300 MHz, CDCl3): δ 8.67 (d, J=5.7 Hz,
8H), 7.56 (s, 2H), 7.49–7.40 (m, 12H), 7.34 (d, J=8.7 Hz,
2H), 7.20 (d, J=8.8 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ
150.75, 149.00, 147.39, 145.68, 141.20, 130.33, 129.84,
126.18, 123.05, 121.80, 121.19. MALDI-HRMS calcd. for
[M+H]+ C38H27ClN5: 588.1950. Found: 588.1950.
2.2 Spectroscopic measurements
Absorption spectra were recorded at room temperature on a
TU-1810DSPC spectrometer from Beijing Purkinje General
Instrument Co., Ltd. (China). Luminescence spectra were
recorded on an F-380 spectrofluorimeter from Tianjin
Gangdong Sci. & Tech. Development Co., Ltd. (China), with
a red-sensitive photomultiplier tube R928F. All measure-
ments were performed in a quartz cuvette with path length of
1 cm. The absolute quantum yields and emission lifetimes
were measured by using the Edinburgh FLS980 spectro-
fluorometer system (England). Fluorescence microscopy
characterization was carried out using Olympus IX83 In-
verted fluorescence microscope (Japan) equipped with a
spot-enhanced charge couple device (CCD, Diagnostic In-
strument, Inc., USA)
2.1.4 N,N-bis(3,5-di(pyrid-4-yl)phenyl)-p-methoxy(phen-
4-yl)aniline (4)
Using the similar procedure for the synthesis of 2, compound
4
was prepared from 3,5-(pyrid-2-yl)bromobenzene
(357.8 mg, 1.15 mmol), 4-(p-methoxyphenyl)aniline
(99.6 mg, 0.50 mmol), Pd(dba)2 (23.0 mg, 0.040 mmol),
tBu3P (8.1 mg, 0.040 mmol), and NaOtBu (120 mg,
1.25 mmol) as a yellow solid in 62% yield (204 mg of pro-
1
duct was isolated). H NMR (400 MHz, CDCl3): δ 8.66 (d,
J=5.5 Hz, 8H), 7.56 (dd, J=8.2, 4.9 Hz, 6H), 7.51 (d, J=
1.3 Hz, 4H), 7.46 (d, J=6.0 Hz, 8H), 7.30 (d, J=8.5 Hz, 2H),
6.98 (d, J=8.7 Hz, 2H), 3.84 (s, 3H). 13C NMR (100 MHz,
CDCl3): δ 159.35, 150.58, 149.15, 147.42, 145.46, 140.89,
137.01, 132.67, 128.08, 127.89, 125.21, 122.91, 121.72,
120.70, 114.46, 55.47. MALDI-HRMS calcd. for [M]+
C45H33N5O: 659.2680. Found: 659.2675.
2.3 X-ray crystallography
The X-ray diffraction data were collected using a Rigaku
Saturn 724 diffractometer (Japan) on a rotating anode (Mo-K
radiation, 0.71073 Å) at 293 K. The structure was solved by
the direct method using SHELXS-97 and refined with Olex2
[71]. The detailed crystallographic data (CCDC 1577194–
1577199) are given in Tables S1 and S2 (Supporting In-
formation online).
2.1.5 N,N-bis(3,5-di(pyrid-4-yl)phenyl)-p-methoxyaniline
(5)
Using the similar procedure for the synthesis of 2, compound
5
was prepared from 3,5-(pyrid-2-yl)bromobenzene
(388 mg, 1.25 mmol), p-anisidine (61.6 mg, 0.50 mmol),
Pd(dba)2 (23.0 mg, 0.040 mmol), tBu3P (8.1 mg,
0.040 mmol), and NaOtBu (120 mg, 1.25 mmol) as a yellow
2.4 Computational methods
1
solid in 70% yield (203.6 mg of product was isolated). H
Density functional theory (DFT) calculations were carried
out using the B3LYP exchange correlation functional and
implemented in the Gaussian 09 package [72]. The electronic
structures of complexes were determined using the 6-31G*
basis set for all atoms. No symmetry constraints were used in
the optimization (nosymm keyword was used). Frequency
calculations have been performed with the same level of
theory to ensure the optimized geometries to be local mini-
ma. All orbitals have been computed at an isovalue of 0.02
e/bohr3. TDDFT calculations were performed on the DFT-
optimized structures on the same level of theory. The emis-
sion wavelength was calculated based on the TDDFT-opti-
mized S1 excited state geometry [73,74].
NMR (400 MHz, CDCl3): δ 8.65 (d, J=4.7 Hz, 8H), 7.49 (s,
2H), 7.43 (dd, J=5.8, 3.5 Hz, 12H), 7.23 (d, J=7.8 Hz, 2H),
6.95 (d, J=7.9 Hz, 2H), 3.86 (s, 3H). 13C NMR (100 MHz,
CDCl3): δ 157.50, 150.67, 149.60, 147.72, 140.85, 139.64,
127.96, 121.92, 121.82, 120.08, 115.67, 55.76. EI-HRMS
calcd. for [M]+ C39H29N5O: 583.2372. Found: 583.2369.
2.1.6 N,N-dimethyl-N′,N′-bis(3,5-di(pyrid-4-yl)phenyl)-p-
phenylenediamine (6)
Using the similar procedure for the synthesis of 2, compound
6
was prepared from 3,5-(pyrid-2-yl)bromobenzene
(388 mg, 1.25 mmol), N,N-dimethyl-p-phenylenediamine